However, GPC3 is highly expressed in 80% of HCC tissues and is closely associated with elevated serum alpha-fetoprotein (AFP) levels (3–5), making it an ideal early diagnostic marker and therapeutic target for HCC. Here, AFP is linked to hepatocellular carcinoma.